Even low levels of leisure-time physical activity can prevent stroke in the long term

As­traZeneca is gain­ing a late-stage RSV vac­cine can­di­date as part of its pro­posed ac­qui­si­tion of Icosavax af­ter the British drug­mak­er spent two years search­ing for

An­nex­on Bio­sciences re­port­ed new Phase 3 da­ta for its Guil­lain-Bar­ré Syn­drome (GBS) drug Tues­day morn­ing, say­ing the low dose achieved the tri­al’s pri­ma­ry end­point. …

Labcorp has completed the spin-off of Fortrea. Image credit: Shutterstock Labcorp, the laboratory service supplier based in the US, has completed the spin-off of Fortrea,